Member of the Association of American Physicians
His main research concerns Pulmonary hypertension, Pathology, Hypoxia, Lung and Cell biology. His research on Pulmonary hypertension concerns the broader Internal medicine. His biological study spans a wide range of topics, including Progenitor cell and Respiratory disease.
His Hypoxia research includes themes of Blood vessel, Circulatory system and Histone deacetylase. His Lung research is multidisciplinary, relying on both Persistent Fetal Circulation Syndrome, Mesenchymal stem cell, Hypoxemia and Respiratory system. Kurt R. Stenmark has researched Cell biology in several fields, including Cell, Cell growth, Paracrine signalling, Immunology and Molecular biology.
Pulmonary hypertension, Internal medicine, Pathology, Hypoxia and Pulmonary artery are his primary areas of study. His Pulmonary hypertension research incorporates themes from Cancer research, Inflammation, Immunology, Lung and Pharmacology. The concepts of his Internal medicine study are interwoven with issues in Endocrinology and Cardiology.
His Pathology study combines topics from a wide range of disciplines, such as Progenitor cell, Respiratory disease and Endothelium. His Hypoxia research integrates issues from Blood vessel, Cell growth, Circulatory system, Cell biology and Fibroblast. His Cell biology study combines topics in areas such as Phenotype, Cell, Endothelial stem cell and Vasa vasorum.
The scientist’s investigation covers issues in Pulmonary hypertension, Internal medicine, Cell biology, Hypoxia and Cardiology. His research in Pulmonary hypertension intersects with topics in Cancer research, Pathogenesis, Inflammation, Lung and Macrophage. In Lung, Kurt R. Stenmark works on issues like Pulmonary artery, which are connected to Pharmacology, Smooth muscle, Pathology, Vascular remodelling in the embryo and Vasa vasorum.
His Internal medicine research focuses on Endocrinology and how it connects with Cell. His work deals with themes such as Phenotype, Gene expression, Gene, Paracrine signalling and Fibroblast, which intersect with Cell biology. His research integrates issues of Proinflammatory cytokine, Cell growth and Pulmonary inflammation in his study of Hypoxia.
His primary areas of study are Pulmonary hypertension, Internal medicine, Cardiology, Hypoxia and Cell biology. His Pulmonary hypertension study integrates concerns from other disciplines, such as Pulmonary pathology, Lung, Drug development and Pathology. His work deals with themes such as In vitro, Pulmonary artery and Pharmacology, which intersect with Lung.
His study in the fields of Pulmonary fibrosis, Idiopathic pulmonary fibrosis, COPD and Pulmonary disease under the domain of Internal medicine overlaps with other disciplines such as Large animal. Hypoxia is a primary field of his research addressed under Endocrinology. His work on Extracellular matrix as part of general Cell biology research is often related to Self-healing hydrogels, thus linking different fields of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cellular and molecular pathobiology of pulmonary arterial hypertension.
Marc Humbert;Nicholas W Morrell;Stephen L Archer;Kurt R Stenmark.
Journal of the American College of Cardiology (2004)
Hypoxia-Induced Pulmonary Vascular Remodeling Cellular and Molecular Mechanisms
Kurt R. Stenmark;Karen A. Fagan;Maria G. Frid.
Circulation Research (2006)
Cellular and molecular basis of pulmonary arterial hypertension.
Nicholas W. Morrell;Serge Adnot;Stephen L. Archer;Jocelyn Dupuis.
Journal of the American College of Cardiology (2009)
Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure
Kurt R. Stenmark;Barbara Meyrick;Nazzareno Galie;Wolter J. Mooi.
American Journal of Physiology-lung Cellular and Molecular Physiology (2009)
Inflammation, growth factors, and pulmonary vascular remodeling.
Paul M. Hassoun;Luc Mouthon;Joan A. Barberà;Saadia Eddahibi.
Journal of the American College of Cardiology (2009)
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society
Steven H. Abman;Georg Hansmann;Stephen L. Archer;D. Dunbar Ivy.
Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung
Aimee Y. Yu;Maria G. Frid;Larissa A. Shimoda;Charles M. Wiener.
American Journal of Physiology-lung Cellular and Molecular Physiology (1998)
Relevant issues in the pathology and pathobiology of pulmonary hypertension
Rubin M Tuder;Stephen L Archer;Peter Dorfmüller;Serpil C Erzurum.
Journal of the American College of Cardiology (2013)
Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis.
Maria G. Frid;Vishakha A. Kale;Kurt R. Stenmark.
Circulation Research (2002)
Hypoxia-Induced Pulmonary Vascular Remodeling Requires Recruitment of Circulating Mesenchymal Precursors of a Monocyte/Macrophage Lineage
Maria G. Frid;Jacqueline A. Brunetti;Danielle L. Burke;Todd C. Carpenter.
American Journal of Pathology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: